| Jan 28 | Current Diagnosis of Mesenchymal Neoplasms: A Fusion Between Anatomic and Molecular Pathology | Dr. Jinesa Moodley |
| Feb 26 | Emerging Immunohistochemical Biomarkers in Ovarian Cancer | Dr. Basile Tessier-Cloutier |
2025 CAMP PODS SESSIONS
2024 CAMP PODS SESSIONS
| Feb 1 | Application of Immunohistochemistry and Molecular Diagnostics for Melanocytic Tumors in Routine Practice | Dr. Aleodor (Doru) Andea |
| Mar 7 | Application of Next Generation Molecular Methods for the Detection of Microbial Agents in Pathology | Dr. Gregor Gorkiewicz |
| Jun 6 | Precision Oncology – Paradigm of Integrated Healthcare | Dr. Benedikt Westphalen |
| Aug 1 | MMR Testing in Colorectal Cancer Diagnostic and Interpretation Challenges Testing Pitfalls | Dr. Celia Marginean |
| Aug 15 | Molecular Aspects of Thyroid Pathology | Dr. Vania Nosé |
| Sep 5 | Molecular Pathology of Ovarian Cancer – The Central Role of Pathologist | Dr. Frederique Penault-Llorca |
| Nov 7 | Expanding role of Predictive Biomarker testing in Esophagogastric Cancers – looking beyond HER2 | Dr. Sharlene Gill |
2023 CAMP PODS SESSIONS
| Mar 2 | Integration of Genomics into Cancer Care | Dr. Janessa Laskin |
| Mar 30 | Recent Discoveries on the Diagnosis and Pathogenesis of Mesothelioma | Dr. Lucian R. Chirieac |
| May 4 | Predictive Molecular Pathology in Non-Small Cell Lung Cancer | Dr. Umberto Malapelle |
| Jun 1 | Expect the Unexpected: Molecular Pathology Elucidation of Challenging Anatomic Pathology Cases | Dr. Dara Aisner |
| Jul 6 | Introduction of NTRK immunohistochemistry into the clinical practice – lessons from the CANTrk ring study | Dr. Martin Hyrcza |
| Aug 3 | Towards the Development of a Canadian Training Program in Molecular Diagnostics | Dr. Rashmi Goswami |
| Sep 7 | HER2low Breast Cancer | Dr. Frederique Penault-Llorca |
| Oct 9 | Biobanking in the Era of Precision Medicine | Dr. Marius Ilié |
| Nov 20 | Molecular Pathology of Sarcomas: A Blend of Morphology and Genetics | Prof. Enrique de Álava |
2022 CAMP PODS SESSIONS
| Jan 13 | Pathologic and Molecular Classification of Gastric Carcinomas | Dr. Celia Marginean |
| Feb 3 | The Evolution of Population-based Hereditary Cancer Care in British Columbia and Yukon, Canada | Dr. Kasmintan Schrader |
| Mar 3 | Evaluate the diagnostic toolbox of tomorrow’s thoracic pathologist: focus on liquid biopsy | Dr. Marius Ilié |
| Apr 14 | Community to Academic Pathology – The USCAP 2022 Annual Meeting experience | Dr. Basile Tessier-Cloutier & Dr. Brandon Sheffield |
| Jul 14 | Lung cancer pathology and biomarkers at ASCO 2022 | Dr. Ming Tsao |
| Aug 12 | The old, the new, and the emerging biomarkers in personalized treatment of NSCLC | Dr. Natasha Leighl & Dr. Diana Ionescu |
| Sep 15 | Bioinformatics and Genome Data Processing in Oncology: Opening the Black Box | Dr. Erin Pleasance |
| Nov 3 | What’s Hot in Cold Tumors? Decoding the Lung Cancer Immune Microenvironment and its Biomarker Role | Dr. Kurt Schlaper |
| Dec 15 | Pathology Pot Pourri | Dr. Malcolm Hayes |
2021 CAMP PODS SESSIONS
| Jan 14 | Deep Learning in Pathology – Connecting Morphology with Genome | Dr. Stephen Yip |
| Feb 4 | Molecular Subtyping of Urothelial Carcinoma: Pathological Correlation and Clinical Impact | Dr. Peter Black & Dr. Gang Wang |
| Mar 4 | Nurse Navigator in Oncology: Luxury or Necessity? | Ms. Kelly Zibrik |
| May 6 | Fast Forward to Finding and Treating Fusions (with a focus on Colorectal Cancers) | Dr. Eric Chen & Dr. Jaclyn Hechtman |
| Jun 3 | Update on First-Line Immunotherapy and PD-L1 Testing in HNSCC | Dr. Denis Soulières |
| Aug 5 | ASCO 2021 Pathology Needed for Adjuvant Therapy | Dr. Barb Melosky & Dr. Marie-Hélène Denaul |
| Sep 2 | Personalized Treatment Strategies in Metastatic Colorectal Cancer | Dr. Sharlene Gill |
| Oct 7 | Interpretation of Residual Cancer After Neoadjuvant Treatment for Breast Cancer | Dr. W. Fraser Symmans |
2020 CAMP PODS SESSIONS
| Sep 10 | What Oncologists Want – An Oncologic Pathology Hotline | Dr. Barb Melosky & Dr. Diana Ionescu |
| Oct 1 | Cost Effective Biomarker Testing in Lung Cancer: The Alberta Experiment | Dr. Cheryl Mather |
| Nov 5 | Point of Care Molecular Testing | Dr. Brandon Sheffield |